GLP-1 receptor agonists for obesity: eligibility across 99 countries
GLP-1受体激动剂治疗肥胖症:99个国家的适用性
期刊:Lancet Diabetes & Endocrinology
影响因子:41.8
doi:10.1016/S2213-8587(25)00356-0
Yoo, Sang Gune K; Teufel, Felix; Theilmann, Michaela; Si, Yajuan; Toure, Elhadji A; Aryal, Krishna; Bärnighausen, Till; Bait, Abdul; Barreto, Marta; Bovet, Pascal; Brant, Luisa C C; Cuschieri, Sarah; Damasceno, Albertino; Farzadfar, Farshad; Fawwad, Asher; Geldsetzer, Pascal; Hambleton, Ian R; Houehanou, Corine; Howitt, Christina; J Rgensen, Jutta; González-Rivas, Juan P; Labadarios, Demetre; Marcus, Maja; Martins, Joao; Mwalim, Omar; Nieto-Martínez, Ramfis; Odili, Augustine N; Orazumbekova, Binur; Perman, Gastón; Quesnel-Crooks, Sarah; Moghaddam, Sahar Saeedi; Sewpal, Ronel; Sousa-Uva, Mafalda; Sulola, Mubarak A; Venkataraman, Kavita; Vollmer, Sebastian; Xueling, Sim; Atun, Rifat; Banegas, José R; Franco, Juan V A; Arnott, Clare; Chandiwana, Nomathemba; Huffman, Mark D; Davies, Justine; Ali, Mohammed K; Flood, David; Manne-Goehler, Jennifer